中财网 中财网股票行情
昭衍新药(603127)财务分析指标    年份：
截止日期2025-12-312025-09-302025-06-302025-03-312024-12-31
营业总收入(万元)165762.4398496.1566857.5228733.72201833.38
营业收入(万元)165762.4398496.1566857.5228733.72201833.38
营业总成本(万元)166321.46109943.7766739.4331033.64176374.83
营业成本(万元)131431.2277268.1450793.5320513.29144456.02
净利润(万元)27855.337422.585859.834035.262303.43
归属于母公司的净利润(万元)29784.108070.616093.244111.957407.54
营业利润(万元)33799.119945.207985.554938.2610434.73
利润总额(万元)33749.339962.548011.964938.3710403.91
少数股东损益(万元)0.150.000.000.00-432.03
基本每股收益(元)0.40(元)0.11(元)0.08(元)0.05(元)0.10(元)
稀释每股收益(元)0.40(元)0.11(元)0.08(元)0.05(元)0.10(元)
非经常性损益(万元)--5166.13--1545.69--
扣除非经常性损益后净利润(万元)31147.552904.472305.222566.262357.34
总资产(万元)968190.86953338.27947346.23942465.86939615.26
总负债(万元)135655.75141236.05136839.58131545.27131696.44
归属于母公司股东权益合计(万元)832498.00812065.26810469.68810883.63807881.86
股东权益合计(万元)832535.12812102.22810506.65810920.59807918.83
实收资本(股本)(万元)74947.7374947.7374947.7374947.7374947.73
资本公积(万元)523766.59523766.59523766.59523766.59523766.59
未分配利润(万元)237042.49215328.99213351.62213608.86209496.91
经营活动产生的现金流量净额(万元)44456.6726639.1116277.306514.9233892.87
经营活动现金流入小计(万元)183212.73132347.2087597.8642980.50181138.70
经营活动现金流出小计(万元)138756.06105708.0871320.5636465.58147245.83
投资活动产生的现金流量净额(万元)-41919.29-26472.26-43501.23-33395.98-196302.40
投资活动现金流入小计(万元)237051.18196698.35103847.6261761.37336550.20
投资活动现金流出小计(万元)278970.47223170.61147348.8595157.35532852.60
筹资活动产生的现金流量净额(万元)-6698.41-5898.85-2818.03-1866.51-26562.75
筹资活动现金流入小计(万元)----------
筹资活动现金流出小计(万元)6698.415898.852818.031866.5126562.75
期末现金及现金等价物余额(万元)91185.4390206.0566223.2267657.1296520.31
最后修改日期2026-03-302025-11-012025-08-272025-04-292025-03-28
↑返回页顶↑

转至昭衍新药（603127）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。